Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
850.35
860.94
844.01
819.57
920.20
979.32
920.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
850.35
860.94
844.01
819.57
920.20
979.32
920.64
Raw Material Cost
357.36
523.71
424.89
418.39
397.14
477.20
443.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.07
0.85
0.00
0.41
0.23
1.26
3.00
Selling and Distribution Expenses
272.15
277.29
241.01
267.54
288.12
318.37
282.23
Other Expenses
6.14
5.40
6.53
6.19
6.34
5.77
7.88
Total Expenditure (Excl Depreciation)
690.97
855.88
731.17
748.22
748.87
854.50
807.75
Operating Profit (PBDIT) excl Other Income
159.4
5.1
112.8
71.39999999999999
171.29999999999998
124.80000000000001
112.89999999999999
Other Income
37.88
64.65
77.88
21.86
37.54
56.86
22.38
Operating Profit (PBDIT)
157.10
113.01
218.84
127.06
200.73
206.33
186.90
Interest
0.07
0.85
0.00
0.41
0.23
1.26
3.00
Exceptional Items
-13.18
15.81
3.01
15.52
5.34
-14.32
16.42
Gross Profit (PBDT)
492.99
337.22
419.12
401.17
523.06
502.12
476.92
Depreciation
0.00
55.03
55.03
45.78
45.78
53.44
53.44
Profit Before Tax
143.85
72.95
166.81
96.38
160.05
137.31
146.88
Tax
11.74
32.51
12.91
9.75
15.41
25.24
17.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
130.75
39.24
152.86
85.61
143.54
110.79
127.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
130.75
39.24
152.86
85.61
143.54
110.79
127.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.37
1.14
1.09
1.07
1.07
0.80
1.83
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
132.11
40.38
153.95
86.68
144.61
111.59
129.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,321.95
6,191.18
6,152.79
6,085.04
6,097.18
5,949.56
5,837.06
Earnings per share (EPS)
0.29
0.09
0.34
0.19
0.32
0.24
0.28
Diluted Earnings per share
0.29
0.09
0.34
0.19
0.32
0.24
0.28
Operating Profit Margin (Excl OI)
14.02%
-0.77%
10.18%
7.25%
12.76%
9.81%
12.07%
Gross Profit Margin
16.92%
14.87%
26.28%
17.35%
22.37%
19.48%
21.76%
PAT Margin
15.38%
4.56%
18.11%
10.45%
15.6%
11.31%
13.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -7.59% vs -18.92% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -8.64% vs -10.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -26.96% vs -18.32% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -50.00% vs -84.62% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Cisen Pharmaceutical Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
850.35
0
850.35
Other Operating Income
0.00
0.00
0.00
Total Operating income
850.35
0
850.35
Raw Material Cost
357.36
0
357.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.07
0
0.07
Selling and Distribution Expenses
272.15
0
272.15
Other Expenses
6.14
0.00
6.14
Total Expenditure (Excl Depreciation)
690.97
0
690.97
Operating Profit (PBDIT) excl Other Income
159.38
0.00
159.38
Other Income
37.88
0
37.88
Operating Profit (PBDIT)
157.10
0
157.10
Interest
0.07
0
0.07
Exceptional Items
-13.18
0
-13.18
Gross Profit (PBDT)
492.99
0
492.99
Depreciation
0.00
0
0.00
Profit Before Tax
143.85
0
143.85
Tax
11.74
0
11.74
Provisions and contingencies
0
0
0.00
Profit After Tax
130.75
0
130.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
130.75
0
130.75
Share in Profit of Associates
0
0
0.00
Minority Interest
1.37
0
1.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
132.11
0
132.11
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,321.95
0
6,321.95
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
14.02%
0%
0.00
14.02%
Gross Profit Margin
16.92%
0%
0.00
16.92%
PAT Margin
15.38%
0%
0.00
15.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 85.04 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -1.22% vs 2.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.59% vs -18.92% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.21 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 226.98% vs -73.77% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -8.64% vs -10.85% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.92 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 146.28% vs -65.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -26.96% vs -18.32% in Mar 2025
Quarterly - Interest
Interest 0.01 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -87.50% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.00% vs -84.62% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.02%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
